BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 17630616)

  • 1. Regulation of phosphate homeostasis in infants, children, and adolescents, and the role of phosphatonins in this process.
    Garabedian M
    Curr Opin Pediatr; 2007 Aug; 19(4):488-91. PubMed ID: 17630616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization.
    Quarles LD
    Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E1-9. PubMed ID: 12791601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement.
    Endo I; Fukumoto S; Ozono K; Namba N; Tanaka H; Inoue D; Minagawa M; Sugimoto T; Yamauchi M; Michigami T; Matsumoto T
    Bone; 2008 Jun; 42(6):1235-9. PubMed ID: 18396126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGF23 and disorders of phosphate homeostasis.
    Yu X; White KE
    Cytokine Growth Factor Rev; 2005 Apr; 16(2):221-32. PubMed ID: 15863037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypophosphatemic rickets/osteomalacia. - Mainly on patients with PHEX mutations -].
    Hasegawa Y; Miyamoto J
    Clin Calcium; 2007 Oct; 17(10):1592-9. PubMed ID: 17906414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three novel mutations of the PHEX gene in three Chinese families with X-linked dominant hypophosphatemic rickets.
    Xia W; Meng X; Jiang Y; Li M; Xing X; Pang L; Wang O; Pei Y; Yu LY; Sun Y; Hu Y; Zhou X
    Calcif Tissue Int; 2007 Dec; 81(6):415-20. PubMed ID: 18046499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor 23 and its receptors.
    Yu X; White KE
    Ther Apher Dial; 2005 Aug; 9(4):308-12. PubMed ID: 16076372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal phosphate handling in human--what can we learn from hereditary hypophosphataemias?
    Amatschek S; Haller M; Oberbauer R
    Eur J Clin Invest; 2010 Jun; 40(6):552-60. PubMed ID: 20412291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging role of a phosphatonin in mineral homeostasis and its derangements.
    Bielesz B
    Eur J Clin Invest; 2006 Aug; 36 Suppl 2():34-42. PubMed ID: 16884396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New concepts in pathogenesis of renal hypophosphatemic syndromes.
    Rastegar A
    Iran J Kidney Dis; 2009 Jan; 3(1):1-6. PubMed ID: 19377250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-linked hypophosphatemic rickets and craniosynostosis.
    Murthy AS
    J Craniofac Surg; 2009 Mar; 20(2):439-42. PubMed ID: 19242361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels and dynamic changes of serum fibroblast growth factor 23 in hypophosphatemic rickets/osteomalacia.
    Xia WB; Jiang Y; Li M; Xing XP; Wang O; Hu YY; Zhang HB; Liu HC; Meng XW; Zhou XY
    Chin Med J (Engl); 2010 May; 123(9):1158-62. PubMed ID: 20529556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.
    Jonsson KB; Zahradnik R; Larsson T; White KE; Sugimoto T; Imanishi Y; Yamamoto T; Hampson G; Koshiyama H; Ljunggren O; Oba K; Yang IM; Miyauchi A; Econs MJ; Lavigne J; Jüppner H
    N Engl J Med; 2003 Apr; 348(17):1656-63. PubMed ID: 12711740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypophosphatemia: an update on its etiology and treatment.
    Gaasbeek A; Meinders AE
    Am J Med; 2005 Oct; 118(10):1094-101. PubMed ID: 16194637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone as a source of FGF23: regulation by phosphate?
    Mirams M; Robinson BG; Mason RS; Nelson AE
    Bone; 2004 Nov; 35(5):1192-9. PubMed ID: 15542045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel regulators of phosphate homeostasis and bone metabolism.
    Jüppner H
    Ther Apher Dial; 2007 Oct; 11 Suppl 1():S3-22. PubMed ID: 17976082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into phosphate homeostasis: fibroblast growth factor 23 and frizzled-related protein-4 are phosphaturic factors derived from tumors associated with osteomalacia.
    Kumar R
    Curr Opin Nephrol Hypertens; 2002 Sep; 11(5):547-53. PubMed ID: 12187320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PHEX, FGF23, DMP1 and beyond.
    Strom TM; Jüppner H
    Curr Opin Nephrol Hypertens; 2008 Jul; 17(4):357-62. PubMed ID: 18660670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What have we learnt about the regulation of phosphate metabolism?
    Blumsohn A
    Curr Opin Nephrol Hypertens; 2004 Jul; 13(4):397-401. PubMed ID: 15199289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGF23 concentrations vary with disease status in autosomal dominant hypophosphatemic rickets.
    Imel EA; Hui SL; Econs MJ
    J Bone Miner Res; 2007 Apr; 22(4):520-6. PubMed ID: 17227222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.